Cancer Cell Biology

You have full text access to this OnlineOpen article

Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells

  1. David W. Chan,
  2. Joyce M.F. Lee,
  3. Patrick C.Y. Chan,
  4. Irene O.L. Ng†,*

Article first published online: 13 JUN 2008

DOI: 10.1002/ijc.23634

Issue

International Journal of Cancer

International Journal of Cancer

Volume 123, Issue 5, pages 1043–1052, 1 September 2008

Additional Information

How to Cite

Chan, D. W., Lee, J. M.F., Chan, P. C.Y. and Ng, I. O.L. (2008), Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells. Int. J. Cancer, 123: 1043–1052. doi: 10.1002/ijc.23634

Author Information

  1. Liver Cancer and Hepatitis Research Laboratory and SH Ho Foundation Research Laboratories, Department of Pathology, The University of Hong Kong, Hong Kong

  1. †

    Fax: +852-2872-5197

*Room 127B, University Pathology Building, Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong, China

Publication History

  1. Issue published online: 17 JUN 2008
  2. Article first published online: 13 JUN 2008
  3. Manuscript Accepted: 14 MAR 2008
  4. Manuscript Received: 27 NOV 2007

Funded by

  • Hong Kong Research Grants Council Central Allocation Grant. Grant Number: HKU 1/06C
  • University of Hong Kong (URC)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (529K)

References

  • 1
    Chen PJ,Chen DS,Lai MY,Chang MH,Huang GT,Yang PM,Sheu JC,Lee SC,Hsu HC,Sung JL. Clonal origin of recurrent hepatocellular carcinomas. Gastroenterology 1989; 96: 527–9.
  • 2
    Nowell PC. Mechanisms of tumor progression. Cancer Res 1986; 46: 2203–7.
  • 3
    Angst BD,Marcozzi C,Magee AI. The cadherin superfamily: diversity in form and function. J Cell Sci 2001; 114: 629–41.
  • 4
    Takeuchi T,Ohtsuki Y. Recent progress in T-cadherin (CDH13, H-cadherin) research. Histol Histopathol 2001; 16: 1287–93.
  • 5
    Lee SW. H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med 1996; 2: 776–82.
  • 6
    Lee SW,Reimer CL,Campbell DB,Cheresh P,Duda RB,Kocher O. H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo. Carcinogenesis 1998; 19: 1157–9.
  • 7
    Takeuchi T,Misaki A,Chen BK,Ohtsuki Y. H-cadherin expression in breast cancer. Histopathology 1999; 35: 87–8.
    Direct Link:
  • 8
    Takeuchi T,Misaki A,Sonobe H,Liang SB,Ohtsuki Y. Is T-cadherin (CDH13, H-cadherin) expression related to lung metastasis of osteosarcoma? Histopathology 2000; 37: 193–4.
    Direct Link:
  • 9
    Zochbauer-Muller S,Lam S,Toyooka S,Virmani AK,Toyooka KO,Seidl S,Minna JD,Gazdar AF. Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers. Int J Cancer 2003; 107: 612–6.
    Direct Link:
  • 10
    Roman-Gomez J,Castillejo JA,Jimenez A,Cervantes F,Boque C,Hermosin L,Leon A,Granena A,Colomer D,Heiniger A,Torres A. Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa. J Clin Oncol 2003; 21: 1472–9.
  • 11
    Ivanov D,Philippova M,Tkachuk V,Erne P,Resink T. Cell adhesion molecule T-cadherin regulates vascular cell adhesion, phenotype and motility. Exp Cell Res 2004; 293: 207–18.
  • 12
    Kudrjashova E,Bashtrikov P,Bochkov V,Parfyonova Y,Tkachuk V,Antropova J,Iljinskaya O,Tararak E,Erne P,Ivanov D,Philippova M,Resink TJ. Expression of adhesion molecule T-cadherin is increased during neointima formation in experimental restenosis. Histochem Cell Biol 2002; 118: 281–90.
  • 13
    Wyder L,Vitaliti A,Schneider H,Hebbard LW,Moritz DR,Wittmer M,Ajmo M,Klemenz R. Increased expression of H/T-cadherin in tumor-penetrating blood vessels. Cancer Res 2000; 60: 4682–8.
  • 14
    Sun HC,Tang ZY. Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives. J Cancer Res Clin Oncol 2004; 130: 307–19.
  • 15
    Adachi Y,Takeuchi T,Sonobe H,Ohtsuki Y. An adiponectin receptor, T-cadherin, was selectively expressed in intratumoral capillary endothelial cells in hepatocellular carcinoma: possible cross talk between T-cadherin and FGF-2 pathways. Virchows Arch 2006; 448: 311–8.
  • 16
    Riou P,Saffroy R,Comoy J,Gross-Goupil M,Thiery JP,Emile JF,Azoulay D,Piatier-Tonneau D,Lemoine A,Debuire B. Investigation in liver tissues and cell lines of the transcription of 13 genes mapping to the 16q24 region that are frequently deleted in hepatocellular carcinoma. Clin Cancer Res 2002; 8: 3178–86.
  • 17
    Hug C,Wang J,Ahmad NS,Bogan JS,Tsao TS,Lodish HF. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci USA 2004; 101: 10308–13.
  • 18
    Clark SJ,Harrison J,Paul CL,Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994; 22: 2990–7.
  • 19
    Krishan A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 1975; 66: 188–93.
  • 20
    Jones BE,Lo CR,Liu H,Srinivasan A,Streetz K,Valentino KL,Czaja MJ. Hepatocytes sensitized to tumor necrosis factor-alpha cytotoxicity undergo apoptosis through caspase-dependent and caspase-independent pathways. J Biol Chem 2000; 275: 705–12.
  • 21
    Nicoletti I,Migliorati G,Pagliacci MC,Grignani F,Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139: 271–9.
  • 22
    Gavrieli Y,Sherman Y,Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493–501.
  • 23
    Riou P,Saffroy R,Chenailler C,Franc B,Gentile C,Rubinstein E,Resink T,Debuire B,Piatier-Tonneau D,Lemoine A. Expression of T-cadherin in tumor cells influences invasive potential of human hepatocellular carcinoma. FASEB J 2006; 20: 2291–301.
  • 24
    Piao Z,Park C,Kim JJ,Kim H. Deletion mapping of chromosome 16q in hepatocellular carcinoma. Br J Cancer 1999; 80: 850–4.
  • 25
    Chan DW,Ng IO. Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells. J Pathol 2006; 208: 372–80.
    Direct Link:
  • 26
    Huang ZY,Wu Y,Hedrick N,Gutmann DH. T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expression. Mol Cell Biol 2003; 23: 566–78.
  • 27
    Mukoyama Y,Zhou S,Miyachi Y,Matsuyoshi N. T-cadherin negatively regulates the proliferation of cutaneous squamous carcinoma cells. J Invest Dermatol 2005; 124: 833–8.
  • 28
    Wilhelm D,Bender K,Knebel A,Angel P. The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents. Mol Cell Biol 1997; 17: 4792–800.
  • 29
    Yu J,Ni M,Xu J,Zhang H,Gao B,Gu J,Chen J,Zhang L,Wu M,Zhen S,Zhu J. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer 2002; 2: 29.
  • 30
    Cavallaro U,Liebner S,Dejana E. Endothelial cadherins and tumor angiogenesis. Exp Cell Res 2006; 312: 659–67.
  • 31
    Fukuoka T,Hibi K,Nakao A. Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinoma. Anticancer Res 2006; 26: 3333–5.
  • 32
    Hibi K,Nakayama H,Kodera Y,Ito K,Akiyama S,Nakao A. CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer. Br J Cancer 2004; 90: 1030–3.
  • 33
    Takeuchi T,Liang SB,Matsuyoshi N,Zhou S,Miyachi Y,Sonobe H,Ohtsuki Y. Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma. Lab Invest 2002; 82: 1023–9.
  • 34
    Takeuchi T,Liang SB,Ohtsuki Y. Downregulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skin. Mol Carcinog 2002; 35: 173–9.
    Direct Link:
  • 35
    Toyooka S,Toyooka KO,Harada K,Miyajima K,Makarla P,Sathyanarayana UG,Yin J,Sato F,Shivapurkar N,Meltzer SJ,Gazdar AF. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res 2002; 62: 3382–6.
  • 36
    Guan XY,Fang Y,Sham JS,Kwong DL,Zhang Y,Liang Q,Li H,Zhou H,Trent JM. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 2000; 29: 110–6.
    Direct Link:
  • 37
    Kuntzen C,Sonuc N,De Toni EN,Opelz C,Mucha SR,Gerbes AL,Eichhorst ST. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest. Cancer Res 2005; 65: 6780–8.
  • 38
    Du L,Lyle CS,Obey TB,Gaarde WA,Muir JA,Bennett BL,Chambers TC. Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent. J Biol Chem 2004; 279: 11957–66.
View Full Article (HTML) Get PDF (529K)